
Loading, please wait...

Loading, please wait...

Redcliffe Labs recently announced the Redcliffe Labs COO appointment by elevating Gaurav Jain to this pivotal leadership role. Jain previously served as the Senior Vice President and Head of Growth within the organization. Consequently, this promotion reflects the company's commitment to internal talent development while scaling its operations. Jain brings over twenty years of experience in pharmaceuticals and diagnostics to his new position. This extensive expertise will support the company's technology-driven diagnostic platform.
In his new capacity, Jain will lead several growth initiatives across India. He will also oversee daily operations and maintain clinical quality standards. Furthermore, Redcliffe Labs aims to scale its preventive diagnostics services significantly. Jain joined the organization in November 2021. Since then, he has spearheaded the development of an extensive home-collection phlebotomy network. This network has strengthened last-mile connectivity and service reach for patients across the country.
The diagnostic chain has already touched over one crore lives in India. Additionally, Aditya Kandoi, the Founder and CEO, praised Jain’s ability to deliver impact at scale. Jain stated that the professional journey has been transformational. Moreover, he plans to move India from illness care toward proactive healthcare. This transition is essential for the evolving healthcare landscape. The company continues to focus on nurturing leaders from within to drive innovation.
Q1: Who is the new COO of Redcliffe Labs?
Gaurav Jain is the newly appointed Chief Operating Officer, having previously served as the Senior Vice President and Head of Growth since 2021.
Q2: What are the primary responsibilities of the new COO?
Jain will oversee operations, clinical quality, and growth initiatives to scale the company's technology-driven preventive diagnostics platform.
Q3: How many patients has Redcliffe Labs served to date?
Redcliffe Labs has impacted more than one crore (ten million) lives across India through its diagnostic services.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Redcliffe Labs elevates Gaurav Jain to Chief Operating Officer to drive strategic growth and enhance preventive diagnostic services across the Indian market...
4 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today